Nanobiotix has completed the transfer of NANORAY-312 sponsorship, initiated in 3Q2024, in the majority of regions along with the transfer of full operational control of the Phase 3 clinical trial to ...
In vivo, ARV-806 demonstrated robust and durable KRAS G12D degradation, leading to significant tumor growth inhibition in models of pancreatic, ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing ...
Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...
Cells at the bottom of a liquid medium begin levitating, then hovering at a particular height. With no physical contact, an ...
Optimal packing problems have inspired mathematicians for centuries. Biophysicists now add a layer to the question: How do ...
MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...
This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...
Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...
First, pick your designation of choice. In this case, it’s Google’s Professional Machine Learning Engineer certification. Then look up the exam objectives and make sure they match your career goals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback